Stockreport

Vertex Pharmaceuticals (VRTX): Valuation Check After Positive CASGEVY Pediatric Data and Kidney Disease Breakthrough Progress [Yahoo! Finance]

Vertex Pharmaceuticals Incorporated  (VRTX) 
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.vrtx.com
PDF See our latest analysis for Vertex Pharmaceuticals. Those CASGEVY and kidney disease updates are landing against a strong backdrop, with the share price at $460.31 af [Read more]